Search

everythinglearnresearchcommunity

for

Search:↓

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Patients with alopecia areata and eosinophilia have more nail issues and severe hair loss.

Iron levels are linked to sleep apnea severity, especially in women with hair loss.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Higher blood sugar levels may lead to more severe hair loss in women.

The document's conclusion cannot be provided because the content is not available.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

Severe hair loss may increase the risk of dying from COVID-19.

Lower 2D:4D ratio and older age increase the risk of severe hair loss in men.

Oxidative stress may play a role in causing alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Lower vitamin D levels are linked to more severe alopecia areata.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Scalp microbiota changes may be linked to inflammation in Alopecia Areata.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Lower SOD enzyme levels are linked to more severe hair loss in men.

Traction alopecia reduces hair density and thickness; proper hair care can help prevent it.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Lower Paraoxonase 1 levels in alopecia areata patients suggest antioxidant treatment might help.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.